Total planned funding: $94,473,686
Allocations
Countries/Regions
India | $94,473,686 |
Organizational Types
Unknown | $47,326,637 |
NGO | $19,562,110 |
Own Agency | $14,818,131 |
University | $3,350,000 |
Implementing Agency | $3,100,000 |
Private Contractor | $2,409,000 |
Multi-lateral Agency | $2,206,808 |
FBO | $1,100,000 |
Host Country Government Agency | $601,000 |
Other USG Agency | $0 |
Program Areas
Governance and Systems | $46,722,906 |
Prevention | $18,050,487 |
Management and Operations | $11,574,033 |
Care | $5,719,131 |
Treatment | $4,906,075 |
Testing | $3,073,262 |
Budget Codes
OHSS: Health Systems Strengthening | $28,361,938 |
HVSI: Strategic Information | $14,950,034 |
HVMS: Management and Operations | $11,574,033 |
HVOP: Sexual Prevention: Other Sexual Prevention | $8,610,402 |
HTXS: Treatment: Adult Treatment | $4,547,804 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,937,275 |
HLAB: Laboratory Infrastructure | $3,410,934 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,383,379 |
HVCT: Testing: HIV Testing and Counseling | $3,073,262 |
HBHC: Care: Adult Care and Support | $2,474,316 |
HKID: Care: Orphans and Vulnerable Children | $1,601,730 |
HVTB: Care: TB/HIV | $1,573,085 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,079,190 |
HMBL: Biomedical Prevention: Blood Safety | $1,040,241 |
PDTX: Treatment: Pediatric Treatment | $334,794 |
PDCS: Care: Pediatric Care and Support | $70,000 |
HTXD: Treatment: ARV Drugs | $23,477 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$47,326,637
Countries/Regions
FHI 360:
$14,064,357
Countries/Regions
USG Aggregated Agencies:
$9,702,094
Countries/Regions
University of Washington:
$3,350,000
Countries/Regions